Do no harm: On the ethics of testosterone replacement therapy for HIV+ persons
- 1 January 1997
- journal article
- editorial
- Published by Taylor & Francis in The Journal of Sex Research
- Vol. 34 (1) , 35-36
- https://doi.org/10.1080/00224499709551862
Abstract
This critique of the practice of testosterone replacement therapy for HIV+ individuals and of Wagner, Rabkin, and Rabkin's (1997) research on this topic focuses on (a) the dubious ethics of stimulating sexual desire and sexual function in persons who carry a fatal, sexually borne pathogen, (b) our very limited ability to ensure that testosterone replacement therapy for HIV+ persons will not pose significant danger to uninfected persons, and (c) the relative importance of quality of life versus protection of life considerations in research and therapy in the HIV/AIDS area.Keywords
This publication has 11 references indexed in Scilit:
- Effects of testosterone replacement therapy on sexual interest, function, and behavior in HIV+ menThe Journal of Sex Research, 1997
- Predictive value of viral load measurements in asymptomatic untreated HIV-1 infectionAIDS, 1996
- Condom use among HIV-infected patients in South Bronx, New YorkAIDS, 1996
- A randomized trial of an education, and support program for HIV-infected individualsAIDS, 1995
- Understanding AIDS: A guide for mental health professionals.Published by American Psychological Association (APA) ,1995
- Reasons for inconsistent AIDS‐preventive behaviors among gay menThe Journal of Sex Research, 1993
- Factors associated with severity of depression and high-risk sexual behavior among persons diagnosed with human immunodeficiency virus (HIV) infection.Health Psychology, 1993
- Changing AIDS-risk behavior.Psychological Bulletin, 1992
- Psychotherapist responsibility in notifying individuals at risk for exposure to HIVThe Journal of Sex Research, 1988
- Ethical Issues in Psychological Research on AIDSJournal of Homosexuality, 1986